Literature DB >> 26102280

Clinical chemistry measurements with commercially available test slides on a smartphone platform: Colorimetric determination of glucose and urea.

Yuanyuan Wu1, Anukul Boonloed1, Neal Sleszynski1, Myra Koesdjojo1, Chadd Armstrong1, Shay Bracha2, Vincent T Remcho3.   

Abstract

BACKGKROUND: Rapidly increasing healthcare costs in economically advantaged countries are currently unsustainable, while in many developing nations, even 50-year-old technologies are too expensive to implement. New and unconventional technologies are being explored as solutions to this problem. In this study, we examined the use of a smartphone as the detection platform for 2 well-developed, relatively inexpensive, commercially available clinical chemistry assays as a model for rapid and inexpensive clinical diagnostic testing.
METHODS: An Apple iPhone 4 camera phone equipped with a color analysis application (ColorAssist) was combined with Vitros® glucose and urea colorimetric assays. Color images of assay slides at various concentrations of glucose or urea were collected with the iPhone 4 and quantitated in three different spectral ranges (red/green/blue or RGB) using the ColorAssist app. When the diffuse reflectance data was converted into absorbance, it was possible to quantitate glucose or blood urea nitrogen (BUN) over their clinically important concentration ranges (30-515mg/dl for glucose or 2-190mg/dl for BUN), with good linearity (R(2)=0.9994 or 0.9996, respectively [n=5]).
RESULTS: Data collected using the iPhone 4 and canine serum samples were in agreement with results from the instrumental "gold standard" (Beckman Coulter AU480 Chemistry System) (R(2)=0.9966 and slope=1.0001 for glucose; R(2)=0.9958 and slope=0.9454 for BUN). Glucose determinations of serum samples made using this smartphone method were as accurate as or more accurate than a commercial colorimetric dry slide analyzer (Heska® Element DC Chemistry Analyzer, Loveland, CO) and 2 glucometers: ReliOn® Ultima (Abbott Diabetes Care Inc) and Presto® (AgaMatrix Inc.H). BUN determinations made using the smartphone approach were comparable in accuracy to the Heska instrument.
CONCLUSION: This demonstration shows that smartphones have the potential to be used as simple, effective colorimetric detectors for quantitative diagnostic tests, and may be applicable for both point-of-care applications in the developed world and field deployment in developing nations.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Colorimetric analysis; Glucose; Point-of-care; Smartphone; Urea

Mesh:

Substances:

Year:  2015        PMID: 26102280     DOI: 10.1016/j.cca.2015.05.020

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  5 in total

Review 1.  Nanozyme-based colorimetric biosensor with a systemic quantification algorithm for noninvasive glucose monitoring.

Authors:  Hee-Jae Jeon; Hyung Shik Kim; Euiheon Chung; Dong Yun Lee
Journal:  Theranostics       Date:  2022-09-07       Impact factor: 11.600

2.  Re-usable electrochemical glucose sensors integrated into a smartphone platform.

Authors:  Amay J Bandodkar; Somayeh Imani; Rogelio Nuñez-Flores; Rajan Kumar; Chiyi Wang; A M Vinu Mohan; Joseph Wang; Patrick P Mercier
Journal:  Biosens Bioelectron       Date:  2017-10-13       Impact factor: 10.618

3.  Design, fabrication, and feasibility analysis of a colorimetric detection system with a smartphone for self-monitoring blood glucose.

Authors:  Hung-Chih Wang; Fuh-Yu Chang; Tung-Meng Tsai; Chieh-Hsiao Chen; Yen-Yu Chen
Journal:  J Biomed Opt       Date:  2019-02       Impact factor: 3.170

4.  Noninvasive Hemoglobin Level Prediction in a Mobile Phone Environment: State of the Art Review and Recommendations.

Authors:  Md Kamrul Hasan; Md Hasanul Aziz; Md Ishrak Islam Zarif; Mahmudul Hasan; Mma Hashem; Shion Guha; Richard R Love; Sheikh Ahamed
Journal:  JMIR Mhealth Uhealth       Date:  2021-04-08       Impact factor: 4.773

Review 5.  Smartphone-based clinical diagnostics: towards democratization of evidence-based health care.

Authors:  I Hernández-Neuta; F Neumann; J Brightmeyer; T Ba Tis; N Madaboosi; Q Wei; A Ozcan; M Nilsson
Journal:  J Intern Med       Date:  2018-09-12       Impact factor: 8.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.